Search Results for "doxycycline"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for doxycycline. Results 11 to 13 of 13 total matches.

Drugs for Acne

   
The Medical Letter on Drugs and Therapeutics • Feb 05, 2024  (Issue 1695)
of clascoterone.6,7 SYSTEMIC THERAPY ANTIBIOTICS — Oral tetracyclines such as doxycycline and minocycline ...
Acne is common among adolescents and adults. Guidelines for treatment of acne were last published by the American Academy of Dermatology in 2016.
Med Lett Drugs Ther. 2024 Feb 5;66(1695):17-20   doi:10.58347/tml.2024.1695a |  Show IntroductionHide Introduction

Minocycline Foam (Zilxi) for Rosacea

   
The Medical Letter on Drugs and Therapeutics • Nov 16, 2020  (Issue 1611)
activity against Demodex mites.6 Systemic – Oral antimicrobial doses of tetracycline, doxycycline ...
The FDA has approved a 1.5% topical foam formulation of minocycline (Zilxi – Foamix) for treatment of inflammatory lesions of rosacea in adults. It is the only topical minocycline product approved for this indication. The same manufacturer markets minocycline foam 4% (Amzeeq) for treatment of acne in patients ≥9 years old.
Med Lett Drugs Ther. 2020 Nov 16;62(1611):179-80 |  Show IntroductionHide Introduction

Epsolay - A Benzoyl Peroxide Cream for Rosacea

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023  (Issue 1669)
disease, an oral antibiotic such as doxycycline can be used.1-3 THE NEW FORMULATION — In Epsolay ...
Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults. It is the first product containing benzoyl peroxide to be approved in the US for treatment of rosacea. Benzoyl peroxide formulations approved for acne have been used off-label to treat rosacea for years, but itching and burning have limited their use.
Med Lett Drugs Ther. 2023 Feb 6;65(1669):21-2   doi:10.58347/tml.2023.1669c |  Show IntroductionHide Introduction